English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/116319
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
 |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar otros formatos: Exportar EndNote (RIS)Exportar bibText (RIS)Exportar csv (RIS)
Título

New cell wall-affecting antifungal antibiotics

Autor Ribas, Juan Carlos; Durán, Ángel; Cortés, Juan Carlos G.
Fecha de publicación 2013
EditorSpringer
Citación Antimicrobial Compounds: 237-268 (2013)
Serie Current Strategies and New Alternatives
ResumenFungi have emerged worldwide as increasingly frequent causes of healthcare-associated infections. Invasive fungal infections can be life-threatening. However, the number of antifungal agents available and their use in therapy is very limited. Recently, a new family of specific fungal cell wall synthesis inhibitors has emerged as an alternative antifungal therapy and is gaining increasing relevance yearly. The cell wall is a multilayer dynamic structure, essential to the integrity and shape of the fungal cell, whose function is to counteract the osmotic forces that could otherwise produce fungal cell lysis. The cell wall is absent in nonfungal cells, therefore representing a useful target in discovering selective drugs for the treatment of fungal infections without causing toxicity in the host. Although fungi exhibit a considerable diversity in their cell wall structure, all present β(1,3)-, β(1,6)- and α(1,3)-glucans, chitin, and mannoproteins as their major cell wall components. Three different cell wall synthesis inhibitors of the lipopeptide family of echinocandins, named caspofungin, micafungin, and anidulafungin, are commercially available and new classes of cell wall synthesis inhibitors are emerging. This review provides an overview of what is so far known about the different classes of cell wall-affecting antifungal agents and their mechanism of action, offering new alternatives with clinical potential.
Descripción Capítulo 9.
Versión del editorhttp://dx.doi.org/10.1007/978-3-642-40444-3_9
URI http://hdl.handle.net/10261/116319
DOI10.1007/978-3-642-40444-3_9
ISBN 978-3-642-40443-6
Aparece en las colecciones: (IBFG) Libros y partes de libros
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
New cell wall.pdf1,74 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.